25,914 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Occudo Quantitative Strategies LP

Occudo Quantitative Strategies LP acquired a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 25,914 shares of the pharmacy operator's stock, valued at approximately $242,000.

Other hedge funds have also modified their holdings of the company. Brooklyn Investment Group grew its stake in Walgreens Boots Alliance by 21.1% in the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator's stock valued at $44,000 after purchasing an additional 830 shares in the last quarter. Metis Global Partners LLC boosted its holdings in shares of Walgreens Boots Alliance by 4.9% in the 4th quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock valued at $222,000 after buying an additional 1,118 shares during the last quarter. Harbour Investments Inc. grew its stake in shares of Walgreens Boots Alliance by 4.3% in the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock valued at $265,000 after buying an additional 1,165 shares in the last quarter. Unison Advisors LLC increased its holdings in Walgreens Boots Alliance by 2.8% during the fourth quarter. Unison Advisors LLC now owns 43,226 shares of the pharmacy operator's stock worth $403,000 after buying an additional 1,168 shares during the last quarter. Finally, Avantax Advisory Services Inc. increased its holdings in Walgreens Boots Alliance by 2.4% during the fourth quarter. Avantax Advisory Services Inc. now owns 49,896 shares of the pharmacy operator's stock worth $466,000 after buying an additional 1,186 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Wall Street Zen started coverage on Walgreens Boots Alliance in a research note on Wednesday. They set a "hold" rating for the company. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Friday, January 31st. Finally, Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Trading Up 0.2%

Shares of WBA stock traded up $0.03 during mid-day trading on Thursday, reaching $11.21. 1,813,798 shares of the stock traded hands, compared to its average volume of 20,890,457. The stock's fifty day simple moving average is $11.02 and its two-hundred day simple moving average is $10.39. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $16.74. The company has a market cap of $9.69 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. During the same period last year, the company earned $1.20 EPS. The firm's revenue was up 4.1% compared to the same quarter last year. On average, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Chairman Stefano Pessina purchased 832,258 shares of the company's stock in a transaction dated Sunday, April 27th. The shares were purchased at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the transaction, the chairman now owns 145,621,079 shares of the company's stock, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 17.50% of the stock is owned by corporate insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.